Online Program Home
  My Program

All Times EDT

Abstract Details

Activity Number: 64 - Innovative Practical Improvements in Biomarker Development and Evaluation
Type: Invited
Date/Time: Monday, August 9, 2021 : 10:00 AM to 11:50 AM
Sponsor: Section on Medical Devices and Diagnostics
Abstract #314430
Title: Two-Stage Adaptive Design for Prognostic Biomarker Signatures with a Survival Endpoint
Author(s): Mei-Yin C Polley* and Biyue Dai
Companies: University of Chicago and University of Iowa
Keywords: biomarker signature; survival endpoint; adaptive design; c-index; resampling method; validation
Abstract:

Cancer biomarker discoveries typically involve utilizing patient specimens collected as a previously completed clinical trial. In practice, there is often desire to preserve biospecimens for studies that are most likely to yield useful information. We propose a two-stage adaptive design for time-to-event endpoints which terminates the biomarker study in a futility interim if the model performance is unsatisfactory at an early stage. Stage one involves testing whether the measure of discrimination for survival models (C-index) exceeds a pre-specified threshold. We describe the computation of cross-validated C-index and evaluation of the statistical significance using re-sampling techniques. Stage two involves an independent model validation. Our simulation studies show that when the signature performance is undesirable (under the null), the proposed design maintains type I error at the nominal level and has high probabilities of terminating the study early. Under the alternative hypothesis, power of the design depends on the true event proportion, sample size, and targeted improvement in the discriminant measure. Some practical aspects of the proposed method will be discussed.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2021 program